Detalles de la búsqueda
1.
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.
Anticancer Drugs
; 34(1): 178-186, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36539370
2.
Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer.
Br J Cancer
; 124(3): 552-563, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33106584
3.
Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experience.
Anticancer Drugs
; 30(8): 854-858, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31356228
4.
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials.
Breast Cancer Res Treat
; 172(1): 9-21, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30054831
5.
A hnRNP Kâ»AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer.
Int J Mol Sci
; 19(7)2018 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29966326
6.
Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)".
Int J Cancer
; 151(12): 2291-2292, 2022 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35975447
7.
Metastatic Mediastinal Germ-Cell Tumor and Concurrent COVID-19: When Chemotherapy Is Not Deferrable.
Oncologist
; 26(2): e347-e349, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33345433
8.
SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.
J Med Virol
; 93(12): 6444-6446, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34260066
9.
Efficacy and safety of PD1/PDL1 blockade with platinum-based chemotherapy for extensive small cell lung cancer: A pooled analysis of randomized trials.
Eur J Clin Invest
; 51(5): e13483, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33382454
10.
Genitourinary tumours in the targeted therapies era: new advances in clinical practice and future perspectives.
Anticancer Drugs
; 27(10): 917-43, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27400375
11.
Immunotherapy for genitourinary cancer: state of the art and new perspectives.
Anticancer Drugs
; 27(7): 585-99, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27183027
12.
Atezolizumab and bladder cancer: facing a complex disease.
Lancet
; 391(10118): 305-306, 2018 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29413038
13.
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis.
Eur Urol Oncol
; 7(2): 179-188, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37574390
14.
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients.
Ther Adv Urol
; 16: 17562872241244574, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38638242
15.
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.
Cancers (Basel)
; 16(8)2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38672547
16.
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis.
Clin Genitourin Cancer
; 22(2): 56-67.e16, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37798164
17.
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Eur Urol Oncol
; 7(1): 102-111, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481365
18.
Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients.
Sci Rep
; 13(1): 17791, 2023 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37853018
19.
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study.
Ther Adv Urol
; 15: 17562872231187216, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37492625
20.
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?
Expert Rev Anticancer Ther
; 23(5): 545-554, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37017710